Back to REGN
Washington Trust Advisors, Inc. → REGN
Washington Trust Advisors, Inc. REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
10
Latest value
$19.5M
Q3 2026
Peak value
$22.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $65K |
| Q3 2025 | $16.6M |
| Q4 2025 | $89K |
| Q4 2025 | $22.6M |
| Q1 2026 | $90K |
| Q1 2026 | $22.1M |
| Q2 2026 | $74K |
| Q2 2026 | $17.2M |
| Q3 2026 | $90K |
| Q3 2026 | $19.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19.5M | 25.7K | — | — |
| Q3 2026 | $90K | 119 | — | — |
| Q2 2026 | $17.2M | 27.6K | — | — |
| Q2 2026 | $74K | 119 | — | — |
| Q1 2026 | $22.1M | 28.6K | — | — |
| Q1 2026 | $90K | 116 | — | — |
| Q4 2025 | $22.6M | 29.3K | — | — |
| Q4 2025 | $89K | 115 | — | — |
| Q3 2025 | $16.6M | 29.6K | — | — |
| Q3 2025 | $65K | 115 | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B